Essais liés3clinical trials
VilleMunichlocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06411288

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
AOC 1001 (del-desiran) Myopathies Phase 3 NCT06411288 HARBOR — Global Study of Del-desiran for the Treatment of DM1 COMPLETED
Sevasemten 10 mg Myopathies Phase 2 NCT05291091 Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) ACTIVE_NOT_RECRUITING
Sevasemten Myopathies Phase 2 NCT06066580 MESA — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy ENROLLING_BY_INVITATION